Atrial Fibrillation Market Report (2022 to 2030)

Pune, Oct. 28, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global atrial fibrillation market is expected to clock US$ 2.4 billion by 2030 and to grow at a CAGR of 6.3% during the forecast period. The high prevalence of atrial fibrillation and the increasing geriatric population are the prime reason for the expansion of the market. This exclusive information is published by Growth Plus Reports in its report titled “Atrial Fibrillation Market – Global Outlook & Forecast 2022-2030”

Download PDF Brochure of Atrial Fibrillation Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/atrial-fibrillation-market/7897

Market driver

The incidence and prevalence of atrial fibrillation (AFib) have increased by almost 33% globally over the past 20 years, with high sociodemographic indices showing the highest impact. The significant rise in AFib prevalence can be attributed to several factors, including the aging of the global population, the prolonged survival of people with cardiac conditions that increase their risk of atrial fibrillation, and the rising prevalence of AFib risk factors like hypertension and obesity in the population at risk. Atrial fibrillation is also in demand due to improvements in detection technologies and an increase in the use of electrocardiography (ECG), both in conventional clinical settings and through wearable or implantable devices with continuous AFib-detecting capabilities. Increased comorbidities such as a high body mass index, diabetes, hypertension, and chronic lung disease can further contribute to the rising acceptance of AFib.

Excerpts from ‘By End-user Segmentation’

Based on end-user, the global atrial fibrillation market has been segmented into:

• Hospitals
• Specialty Clinics
• Electrophysiology
• Others

Hospitals have seen the most revenue growth due to laser and radiofrequency catheter ablation…